FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137598374> ?p ?o ?g. }

• W3137598374 endingPage "46" @default.
• W3137598374 startingPage "42" @default.
• W3137598374 abstract "Long-acting injectable antipsychotics (LAI-APs) remain underutilized. One reason is the concern that LAI-APs might cause serious adverse events such as neuroleptic malignant syndrome (NMS) and lead to prolonged symptoms compared with oral treatment. Because the risk of NMS associated with LAI second-generation antipsychotics (LAI-SGAs) remains unclear, we compared reporting frequency, time to onset, and mortality of NMS between LAI- and oral SGAs using data from a Japanese spontaneous adverse event reporting database between April 2004 and September 2019. Of 5791 patients reporting adverse events due to LAI-SGAs or the equivalent oral SGAs, 768 (13%) developed NMS. LAI aripiprazole and LAI paliperidone were associated with a significantly lower reporting frequency of NMS than the equivalent oral SGAs (adjusted reporting odds ratio [95% confidence interval]: 0.35 [0.19–0.63] and 0.40 [0.27–0.59], respectively). Between 42% and 62% of the NMS associated with LAI- and oral SGAs other than LAI risperidone occurred within 30 days after initiation. The proportion of mortality due to NMS associated with oral aripiprazole was 13.1% and no deaths occurred in patients with NMS associated with LAI aripiprazole. The proportions of mortality due to NMS associated with oral risperidone/paliperidone, LAI risperidone, and LAI paliperidone were 8.8%, 4.2%, and 3.4%, respectively. Our findings showed that LAI-SGAs were not associated with a higher reporting frequency and mortality of NMS compared with oral SGAs, although clinicians need to closely monitor the occurrence of NMS not only during oral SGA treatment, but also, and in particular, in the early stage of LAI-SGA treatment." @default.
• W3137598374 created "2021-03-29" @default.
• W3137598374 creator A5005239900 @default.
• W3137598374 creator A5006005694 @default.
• W3137598374 creator A5015960933 @default.
• W3137598374 creator A5050569773 @default.
• W3137598374 creator A5052642593 @default.
• W3137598374 date "2021-05-01" @default.
• W3137598374 modified "2023-10-16" @default.
• W3137598374 title "Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan" @default.
• W3137598374 cites W1986060217 @default.
• W3137598374 cites W2027471441 @default.
• W3137598374 cites W2031792451 @default.
• W3137598374 cites W2042749834 @default.
• W3137598374 cites W2059403801 @default.
• W3137598374 cites W2063432330 @default.
• W3137598374 cites W2086049425 @default.
• W3137598374 cites W2088866491 @default.
• W3137598374 cites W2120840334 @default.
• W3137598374 cites W2134675761 @default.
• W3137598374 cites W2158299492 @default.
• W3137598374 cites W2158322055 @default.
• W3137598374 cites W2325486128 @default.
• W3137598374 cites W2343480621 @default.
• W3137598374 cites W2407985491 @default.
• W3137598374 cites W2476725984 @default.
• W3137598374 cites W2740548674 @default.
• W3137598374 cites W2970371250 @default.
• W3137598374 cites W3029731088 @default.
• W3137598374 cites W3038079677 @default.
• W3137598374 doi "https://doi.org/10.1016/j.schres.2021.02.016" @default.
• W3137598374 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33752105" @default.
• W3137598374 hasPublicationYear "2021" @default.
• W3137598374 type Work @default.
• W3137598374 sameAs 3137598374 @default.
• W3137598374 citedByCount "6" @default.
• W3137598374 countsByYear W31375983742022 @default.
• W3137598374 countsByYear W31375983742023 @default.
• W3137598374 crossrefType "journal-article" @default.
• W3137598374 hasAuthorship W3137598374A5005239900 @default.
• W3137598374 hasAuthorship W3137598374A5006005694 @default.
• W3137598374 hasAuthorship W3137598374A5015960933 @default.
• W3137598374 hasAuthorship W3137598374A5050569773 @default.
• W3137598374 hasAuthorship W3137598374A5052642593 @default.
• W3137598374 hasConcept C118552586 @default.
• W3137598374 hasConcept C126322002 @default.
• W3137598374 hasConcept C156957248 @default.
• W3137598374 hasConcept C197934379 @default.
• W3137598374 hasConcept C2776412080 @default.
• W3137598374 hasConcept C2777126507 @default.
• W3137598374 hasConcept C2780057945 @default.
• W3137598374 hasConcept C2780211496 @default.
• W3137598374 hasConcept C44249647 @default.
• W3137598374 hasConcept C71924100 @default.
• W3137598374 hasConceptScore W3137598374C118552586 @default.
• W3137598374 hasConceptScore W3137598374C126322002 @default.
• W3137598374 hasConceptScore W3137598374C156957248 @default.
• W3137598374 hasConceptScore W3137598374C197934379 @default.
• W3137598374 hasConceptScore W3137598374C2776412080 @default.
• W3137598374 hasConceptScore W3137598374C2777126507 @default.
• W3137598374 hasConceptScore W3137598374C2780057945 @default.
• W3137598374 hasConceptScore W3137598374C2780211496 @default.
• W3137598374 hasConceptScore W3137598374C44249647 @default.
• W3137598374 hasConceptScore W3137598374C71924100 @default.
• W3137598374 hasLocation W31375983741 @default.
• W3137598374 hasOpenAccess W3137598374 @default.
• W3137598374 hasPrimaryLocation W31375983741 @default.
• W3137598374 hasRelatedWork W2120641313 @default.
• W3137598374 hasRelatedWork W2221129520 @default.
• W3137598374 hasRelatedWork W2343771400 @default.
• W3137598374 hasRelatedWork W2783694945 @default.
• W3137598374 hasRelatedWork W3119216916 @default.
• W3137598374 hasRelatedWork W3172922213 @default.
• W3137598374 hasRelatedWork W4246233321 @default.
• W3137598374 hasRelatedWork W4318040216 @default.
• W3137598374 hasRelatedWork W4366716821 @default.
• W3137598374 hasRelatedWork W4380150031 @default.
• W3137598374 hasVolume "231" @default.
• W3137598374 isParatext "false" @default.
• W3137598374 isRetracted "false" @default.
• W3137598374 magId "3137598374" @default.
• W3137598374 workType "article" @default.